Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors.

Eitemau Tebyg

• Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation.
  gan: Liebow, C, et al.
  Cyhoeddwyd: (1991)
• Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
  gan: Liebow, C, et al.
  Cyhoeddwyd: (1989)
• Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.
  gan: Kadar, T, et al.
  Cyhoeddwyd: (1988)
• Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
  gan: Schally, A V, et al.
  Cyhoeddwyd: (1987)
• Highly potent metallopeptide analogues of luteinizing hormone-releasing hormone.
  gan: Bajusz, S, et al.
  Cyhoeddwyd: (1989)